CooperCompanies to Participate in the Oppenheimer Annual Healthcare Conference
February 18 2020 - 4:15PM
CooperCompanies (NYSE:COO), will participate in the Oppenheimer
30th Annual Healthcare Conference in New York City, NY, on March
17, 2020. Daniel McBride, Esq, Executive Vice President, Chief
Operating Officer & President of CooperVision, will represent
the Company in a session scheduled to begin at 1:00PM ET. A webcast
of the session will be available on the Investor Relations section
of the Company's website at http://investor.coopercos.com.
About CooperCompanies CooperCompanies
("Cooper") is a global medical device company publicly traded on
the NYSE (NYSE:COO). Cooper operates through two business units,
CooperVision and CooperSurgical. CooperVision brings a refreshing
perspective on vision care with a commitment to developing a wide
range of high-quality products for contact lens wearers and
providing focused practitioner support. CooperSurgical is committed
to advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon,
Calif., Cooper has a workforce of more than 12,000 with products
sold in over 100 countries. For more information, please visit
www.coopercos.com.
Contact:Kim DuncanVice President, Investor Relations and Risk
Management925-460-3663ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2023 to Apr 2024